Predicting functional results of percutaneous coronary intervention using machine learning modelling
International Journal of CardiologyResearch Authors: Simone Fezzi, Yueyun Zhu, Norma Bargary, Daixin Ding, Roberto Scarsini, Mattia Lunardi, Antonio Maria Leone, Concetta Mammone, Max Wagener, Angela Mcinerney, Gabor G. Toth, Gabriele Pesarini, David Connolly, Carlo Trani, Shengxian Tu, Francesco Burzotta, Flavio Ribichini, Andrew J. Simpkin, William WijnsAIIM Authors: Husayn Ladha, Amine NoureddineApproved by President Reda RiffiPublication Date: 1/17/2026Comprehensive Summary
Fezzi et al. developed and internally validated machine-learning models to predict post-procedural coronal physiology, measured as Murray’s law-based quantitative flow ratio (μFR), using only pre-PCI clinical, angiographic, and physiological data. The study pooled two prospective European cohorts, including 343 vessels from 291 patients undergoing clinically indicated PCI. Four machine-learning approaches were trained and compared using 1,000 bootstrap iterations, with model selection based on lowest root mean square error for continuous prediction. The selected model accurately predicted post-PCI μFR (RMSE: 0.036, MAE: 0.030, MAPE: 3.2%), despite limited correlation between pre- and post-PCI μFR values. Predicted μFR values were then used to classify PCI outcomes as optimal (μFR ≥ 0.91) or sub-optimal, achieving moderate discrimination (accuracy: 0.72, AUC: 0.72) with high sensitivity (0.90) but low specificity (0.29). Physiological disease pattern and vessel geometry, particularly focal disease and larger reference vessel diameter, were strongly associated with higher post-PCI μFR.
Outcomes and Implications
This proof-of-concept study suggests that machine-learning models can reliably estimate post-PCI coronary physiology before intervention, supporting the concept of “virtual PCI” planning. The high sensitivity of predicted μFR for identifying physiologically optimal outcomes may be useful for upfront procedural decision-making, helping operators anticipate suboptimal results and tailor preparation or treatment strategy accordingly. But the modest specificity reflects the limitations of dichotomozing a continuous physiological variable near a fixed threshold, especially in cohorts with typically high post-PCI μFR values. The lack of external validation, limited outcome events, and narrow post-PCI μFR values. Further prospective studies are needed to determine whether pre-procedural μFR prediction improves procedural strategy, reduces residual ischemia, or translates into better long-term patient outcomes.
Connect medicine with AI innovation.
No spam. Only the latest AI breakthroughs, simplified and relevant to your field.